This site contains promotional information intended only for healthcare professionals resident in the United Kingdom
Sign in
Sign in
Sign out

Information relating to specific disease areas aligned to Pfizer’s portfolio and other resources designed for Pfizer medicines.

See all Therapy areas

Explore Content

Prescribing Information for NGENLA▼(somatrogon) can be found here. Prescribing Information for Genotropin (somatropin) can be found here. Adverse event reporting information can be found at the bottom of the page.

Ordering codes

Product Name

PIP Code

Ngenla 24mg solution for injection in pre filled pen (GB)

540-0098

Ngenla 60mg solution for injection in pre filled pen (GB)

540-0080

Ngenla 24mg solution for injection in pre filled pen (NI)

520-2551

Ngenla 60mg solution for injection in pre filled pen (NI)

520-2569

NGENLA devices & dose increments​​​​​​​1

​​​​​​​For more information about the device, dosing and storage, click here.​​​​​​​

The recommended dose is 0.66mg/kg bodyweight administered once weekly by subcutaneous injection.
​​​​​​​

Device type

Dose setting increments

Suggested dose

24mg solution for
injection pre ​​​​​​​filled pen

0.2mg

Suggested for doses less than 12mg (bodyweight <18kg).

60mg solution for
injection pre filled pen

0.5mg

Suggested for doses of 12mg and above (bodyweight 18kg or over).

Ordering needles/starter kits​​​​

The Endocrine Helpline can support patients by placing an order for consumable items such as needles, sharps bins and patient literature.

The service can also support clinicians in ordering starter kits for patients starting on NGENLA.

Pfizer will provide a box of needles as standard within the patient starter box:
         
            - BD Micro-Fine Ultra 4mm 32G needles (quantity 100)

For resupply, or to order additional or different needles at no cost, the patient/caregiver or Healthcare Professional can contact the Endocrine Helpline on 0800 521249 or [email protected] 


Explore more

Find out information about the starter kits available to patients starting treatment with NGENLA.

Starter Kits

Access the document to support initiation of NGENLA.
​​​​​​​​​​​​​​

Formulary pack
References:

​​​​​​​1. ​​NGENLA Summary of Product Characteristics for Great Britain: https://www.medicines.org.uk/emc/search?q=ngenla & Northern Ireland: https://www.emcmedicines.com/en-gb/northernireland/medicine?id=4319e9d0-5396-4363-8dcb-bc72051b39da&type=smpc
​​​​​​​
PP-NGE-GBR-0037. May 2022.

Learn more about how NGENLA is stored, recommended dosing, and adminstration.
​​​​​​

Dosing & Storage

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in Google Play or Apple App Store

Adverse events should also be reported to Pfizer Medical Information on 01304 616161

For UK Healthcare Professionals*

These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.

I confirm that I am a healthcare professional* resident in the United Kingdom.

If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.

*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.

PP-PFE-GBR-3863. November 2021

Yes

No

OK, We will need you to sign in before we can determine if you are aligned with a Pfizer promotional colleague.This is an interstitial message to prompt a HCP before they login.

If you have already registered with pfizerpro.co.uk and select ‘yes’, you will be directed to the sign-in page where you will be required to enter your username and password.

Would you like to register or sign in now?